Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Medsci 204 > Intro, Pharmacodynamics, Pharmacokinetics and ADME > Flashcards

Intro, Pharmacodynamics, Pharmacokinetics and ADME Flashcards

1
Q

What is pharmacodynamics?

A

Study of molecular, biochemical and physiological EFFECTS of drugs on the body systems, AND mechanisms of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is Pharmacokinetics?

A

Study of ADME of drugs (fate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pharmacogenomics

A

Genetic influences on the effectiveness and fates of drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Toxicology

A

Adverse effects of drugs and other toxic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Percentage of drugs from the natural world

A

63% (eg Taxol, anticancer drug from Yew tree)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where do drugs come from? (5 categories)

A
  1. Extract from plants and herbs
  2. From microorganisms
  3. From the body itself (endogenous)
  4. Chemical modification of body’s own hormones/chemical regulators
  5. Chemical synthesis of novel compounds with desirable properties
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Examples of drugs from plants and herbs

A
  1. Opium Poppy (morphine, painkiller, early 1900s)
  2. Digoxin from foxglove leaves (reverse inhib of Na/K ATPase used to treat congestive heart failure, lethal at high doses)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Examples of drugs from microorganisms

A

Penicillin (antibiotics) b-lactam, interferes with bactrial cell wall synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Examples of endogenous drugs

A

Hormones eg insulin, throxine, growth hormone (most now produced by recombinant tech or chemical synthesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Examples of chemical modification of endogenous

A

Hormonal drugs eg ethinyl estradiol (readily absorbed estrogen form)
Anticancer drugs eg 6hercaptopurine, modified base component of DNA to interfere with DNA symth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Examples of chemical synthesis of novel compounds

A 
Eg indomethacin and celecoxib - COX inhibitors (NSAIDS)
eg cimetadine (histamine receptor modulator)
eg Simvastatin (HMG CoA reductase inhibitor for high cholesterol)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Examples of drugs discovered by chance

A 
eg antidepressants monoamine oxidase inhibitors and tricyclic antidepressants (faled TB treatments)
eg cisplatin (platinum containing, used to treat cancers, was for bacteria)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

4 most common proteins that drugs bind to

A
  1. Enzmes
  2. Carrier proteins
  3. Ion channels
  4. Receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Features of receptors

A

At least one binding site

Binding of exogenous ligands results in signal transduction (efficacy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do drugs act on receptors?

A

Drugs act by promoting or inhibiting the process of signal transduction. Must bind with specificity / selectivity (shapes important)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Affinity

A

Attraction of a ligand for receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Efficacy

A

Effect of ligand binding. Max = 1, no effect = 0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Agonists

A

Affinity and efficacy (mimics ligand)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Antagonists

A

Affinity but NO efficacy (prevents signal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Histamine specificity

A 
H1 = allergic reactions, skin
H2 = stomach acid secretion
H3 = CNS, ileum, cardiac tissue, often presynaptic and autoregulatory (WIDESPREAD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is selectivity>

A

Preferential binding to certain subtype. Greater effect at that subtype than others. (eg sabutamol at B2 (lungs) rather than B1 (heart), or selectivity of H1 antihistamines)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Lack of selectivity / specificity in NSAIDS

A

Universally inhibit COX.
COX2 selective for inducible, little effect on constitutive form (rofecoxib, celecoxib)

COX1 = homeostatic mechanisms
COX2 = antiinflammatory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Rate theory

A

Drug effect is proportional to RATE of occupancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Floating receptor model

A

the D-R complex may interact with variety of effectors in the membrane to produce effect (cause different signals depending on what exposed to in microenvironment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Receptor occupancy theory

A

Drug effect is proportional to NUMBER of receptors occupied (michaelis-menten equilibrium D + R D-R )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Receptor plasticity

A

Number and states of receptors changes - mouldability, due to pharmacological, physiological, pathological states. Responsibel for changes in drug effectiveness over time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

2 state receptor model

A

Resting state R Activated state R*

NO LIGAND
Equilibrium favours R

FULL AGONIST (efficacy =1)
Strongly shifted to R*
PARTIAL AGONIST (efficacy 0-1)
Partly shifted to R*

ANTAGONIST (affinity and NO efficacy = 0)
Equilibrium not shifted, no preference for active/inactive. Binds to and inactivates receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

4 types of receptor families

A
  1. Ionotropic (ion channels)
  2. Metabotropic (GPCR)
  3. Catalytic (kinases)
  4. Nuclear/intracellular (transcription)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Structure of ionotropic receptor

A

extracellular N
Extracellular ligand binding domain
4 TM domains (form pore)
extracellular C domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Structure of GPCRs

A

EC N, IC C domain
EC binding domain
IC GProt coupling domain
7 TM domains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Structure of kinase-linked receptors

A

EC N domain, binding domain
1 TM domain
IC C domain, catalytic domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Structure of nuclear receptors

A

NOT MEMBRANE EMBEDDED
Binding domain by C
middle DNA binding domain (Zn fingers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Ionotropic receptors (eg, speed, mechanism)

A

eg nACh, GABA
VERY FAST
Binding causes conf change, ion channel opening
(increase in opening time for nAChR and increase in channel conductance for GlutamateR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

GPCRs (eg, speed, mechanism)

A

eg mAChR, adrenoreceptors
FAST (milliseconds)
Binding causes activation -> opnening or closing of ion channel or generation of second messengers eg cAMP for biol effect
Gs, Gi, Gq

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Protein Kinases (eg, speed, mechanism)

A

eg tyrosine kinase receptors
ACTION TAKES MINUTES TO DAYS
Receptor triggers a kinase cascade (intrinsic or associative). Attach phosphates to proteins for change in structure and function - cell growth and differentiation (regulate gene expression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Example of kinase pathway: Ras/Raf/MAP Kinase

A 
For cell differentiation
GF binds, conformational change.
Receptor dimerisation
Tyrosine autophosphorylation
Phosphorylation of Grb2
Activation of Ras (GDP/GTP exchange)
-> Raf -> Mek -> MAP Kinase -> various transcription factors act on nucleus - GENE TRANSCRIPTION
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Example of kinase pathway: Jak/Stat

A 
For inflammation
Cytokine binds, conformational change
Binding of Jak intracellularly
Phosphorylation of receptor and Jak
Binding and phos of SH2-domain protein (Stat)
Dimerisation of Stat
Acts on nucleus for gene transcription
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Intracellular receptors (eg, time, mechanism)

A

eg Steroid hormone receptors (oestrogen, cortisol, vitamin A)
ACTION SLOW (hours) AND LONG LASTING
Ligands penetrate PM so lipid-soluble
Bind to highly conserved DNA regions (ligand binding and transcriptional control domains)
Alteration in gene transcription and protein synthesis

39
Q

Agonist potency

A

EC50
Lower value = greater potency
Effective concentration that produces 50% of the maximum effect
PD2

40
Q

PD2

A

-log(EC50)
higher value is greater potency
AGONIST

41
Q

Competitive reversible antagonism

A

Antagonist competes directly with agonist for receptor binding
Parallel rightwards curve shift - no depression, but max response occurs at higher agonist concentration
PA2

42
Q

Measurement of potency of competitive reversible antagonism

A

PA2 (parallel right shift)

PA2 = -log[antagonist] + log((EC50pres/EC50abs) - 1)

43
Q

Example of competitive reversible antagonism

A

Propranolol at B1 receptors

Atropine at M

44
Q

Competitive irreversible antagonism

A

Antag competes directly for receptor binding, binds with greater affinity (doesn’t let go)
Non-parallel rightwards shift of concentration-response curve. Spare receptors?
Potency measure PD2’
eg Phenoxybenzamine at H1 receptors

45
Q

Non-competitive antagonism

A

Doesnt bind to same receptor as agonist, or alter agonist binding.
Interfere with cascade of events eg ca2+ channel blockers
Non-parallel rightwards shift in curve, depression of max response
Potency PD2’

46
Q

Partial agonists

A

ACT AS ANTAGONISTS to full agonists
Efficacy less thn 1 so don’t elicit maximum response
Key characteristic is crossover. At high conc, response diminishes
2-state: hold some receptors in the inactive state so can’t bind as well.

47
Q

Inverse agonists

A

Binds receptor and has negative efficacy - turns receptor off - constitutive activity.
Get in the way of agonist binding, like competitive reversible antagonism

48
Q

HOmologous desensitisation

A

acts on itself

Phosphorylation of serine by BARK on adenylate cyclase

49
Q

Heterologous desensitisation

A

One agonist triggers response that desensitises response to different agonist (eg PKA and PKC)

50
Q

Chronic agonist administration leads to…

A

DOWN REGULATION of receptors

eg chronic salbutamol, internalisation of receptors, less available for stimulation, decreased bronchodilation

51
Q

CHronic antagonist administration leads to…

A

UP REGULATION of receptors

Eg chronic propranolol leads to increased synthesis of B1 receptors in heart, less antagonism, decreased drug effect.

52
Q

Clinical significance of receptor population changes

A

Tolerance
Adverse effects
Therapeutic effects (time to build up the effect)

53
Q

Examples of enzymes as drug targets

A

COX and NSAIDS (treat pain and inflammation)

ACE and ACE Inhibitors (captopril, enalaprilat) treat hypertension

54
Q

Drugs that interact with carrier proteins

A

drugs that act on monoamine neurotransmitter uptake proteins
Fluoxetine (Prozac) SSRI
Sibutramine (Reductil) SNRI

55
Q

Fluoxetine mechanism

A

Block reuptake of 5HT for increased conc in synapses. Depression is thought to be from decreased 5HT so antidepressive effect
Serotonin

56
Q

IOn channel blocker examples

A

Anaesthetics (local) Na+ blockers

Cardiovascular conditions Ca2+ blockers (verapamil, nifedipine)

57
Q

Major organs involved in ADME

A
  1. GI tract (absorption)
  2. Liver (metabolism)
  3. Kidney (excretion)
  4. Lungs (absorb / excrete volatile gases)
58
Q

4 main methods of membrane transport

A
  1. Passive transport
  2. Facilitated diffusion
  3. Active transport
  4. Endocytosis
59
Q

Passive diffusion

A

Non polar drugs (lipid soluble)
Conc gradient drives
No energy

60
Q

Facilitated diffusion

A 
Move faster than expected
Oscillating carrier protein
Concentration gradient!
No energy
Usually substrates are sugars and AAs
61
Q

Active transport

A 
Proceed against conc gradient
REQUIRES ATP
Satuable
Liver, kidney, BBB, gut epithelium
Allows accululation, waste removal, protection against toxins
62
Q

Endocytosis

A

Internalise large molecules >1000 (cytokines, hormones, nanoparticles)
Substrate binds to receptor, invag of complex, budding off and delivery

63
Q

Filtration

A

Some drugs pass BETWEEN not through cells
Blood capillary fenestrations, rapid exchange with IF
Glomerular capillaries in kidneys, extremely porous allowing passage of all plasma except >30,000

64
Q

What is absorption / bioavailablility?

A

Passage of drug from administration to general circulation (bloodstream)
IV absorbed completely (100% bioavailability)
Orally has barriers so absorbtion delayed and incomplete

65
Q

Rate of absorption

A

How rapidly does durg reach general circulation?

66
Q

Extent of absorption

A

How much of administered dose enters general circulation (BIOAVAILABILITY - F)
Bioavailabilty = area under concentration-time curve

67
Q

Routes of drug administration

A 
Enteral
  Oral
  Sublingual
  Rectal
Parenteral
  IV
  SC
  Intradermal (into skin)
  Intramusclular
  Lungs (volatile anaesthetics)
68
Q

IV Administration (+/-)

A

(+)
Rapid, precise control (100% bioavailability), avoid absorption/breakdown before entering blood, good for bad drugs too irritating to be taken by mouth eg anticancer drugs

(-)
Skill required (air emb), careful preparation of sterile materials, no recall so hazardous
69
Q

Oral Administration

A

(+)
Safest, most convenient, economic

(-)
Slow effect, unpredictable rate, extent, reproducibility (change day to day, between people)

70
Q

Factors influencing oral bioavailability

A 
Decomposition in Gastric juices (acidic)
Decomposition in hydrolytic gut enzymes
Degradation by gut micro-organisms
Food in gut
Metabolism by gut wall enzymes
Metabolism by liver enzymes prior to reaching systemic circulation

MOST ARE INVOLVED IN EXTENT

71
Q

Rate limiting step of drug absorption

A

Stomach emptying

72
Q

Patient factors inflencing absorption

A

Stomach emptying rate! (increase in hunger, metoclopramide. Decrease hot meals, narcotics, anticholinergics, TCA anti-depressants)

Intestinal motility (increased due to gastroenteritis, diarrhoea. Decreased by various drugs (narcotics, anticholinergics, tricyclics)

Interactions with foods (chelation of tetracycline with metal ions, becomes insoluble and so is not absorbed)

73
Q

Only kind of drugs to diffuse across BBB

A

Lipid-soluble

Additional layer of glial cells in BBB

74
Q

Body fluid compartments. How much intracellular fluid?

A

28L

75
Q

Body fluid compartments. How much Extracellular fluid?

A

11L ECF + 3L Plasma = 14L

76
Q

Sites of drug metabolusm

A 
LIVER
GI tract - gut bacteria and proteases
Intestinal wall - CYPs
Plasma - esterases
Specialised tissues (monoamine oxidases in nerve endings, noradr to adrenaline)
77
Q

Result of drug metabolism

A

More H2O soluble metabolite
Less likely to diffuse into cells to have action (decreased lipid solubiluty)
Increased excretion (urine or bile)
Usually abolishes activity
UNLESS prodrug (promotes) eg Zidovudine
OR no change in activity (valium diazepam to nordiazepan has v similar activity)
OR produces toxic metabolites, paracetamol

78
Q

Phases of Drug Metabolism

A
  1. Addition / uncovering rective group (oxidation / reduction / hydrolysis - make more susceptible to phase 2)
  2. Conjugation of endogenous molecule to drug (glucuronide, sulphate, GSH, acetylation/methylation - makes molecule more polar, ideal for active transport and EXCRETION)
79
Q

Most important Phase 1 Metabolism Reaction

A

OXIDATION
Cytochrome P450 mixed oxidases (smooth ER)
Requires O2, NADPH, CP450 Reductase

80
Q

Metabolism of Phenytoin

A
  1. Hydroxylation by CYP (now slightly water soluble)

2. Conjugation by UDP glucuronosyl transferase (now very soluble in water)

81
Q

Factors influencing drug metabolism

A

Organ function (kidney, liver, heart, gut).
Diseases, other drugs.
Diet, cigarrettes, alcohol
Age, sex, pregnancy

82
Q

Induction of drug metabolism

A

Enzyme synth initiated within 24h of exposure, increasing over 5 days, decreases over 1-3w afer inducing agent discontinued
Environmental factors:
Cigarette smoking, eating BBQ meat, cruciferous veges, high protein diet, ethanol, insecticides.
Other drugs: barbiturates, phenytoin, rifampicin, st John’s wort (potent inducers of drug metabolising enzymes)

83
Q

Reversible inhibitors of drug metabolusm

A

cimetidine, ketoconazole, quinolone antibiotics, HIV protease inhibitors, grapefruit juice

Lead to EXAGGERATED RESPONSE with increased risk of toxicity.

84
Q

Smokers and Caffeine

A

Smokers have an increased ability to metabolise some drugs and chemicals. Smokers have to drink 50% more coffee to get same effect

85
Q

Reason for variability in therapeutic benefit among population

A

Different ability to metabolise drugs

86
Q

Excretion

A

Compounds are removed from the body to the external environment

87
Q

Site of excretion

A

Kidney - important
biliary excretion - some large drugs >400 and ionised eg glucuronides
Lungs - anaesthetic gases

88
Q

The kidney’s role in excretion

A

Removes H2O soluble drugs and metabolites

89
Q

3 main mechanisms of drug excretion by the kidney

A
  1. Glomerular filtration of unbound drug (130mL/min ~10% RBF)
  2. Active secretion of free and prot-bound drug by transporters (anions and cations) (Prox tubule)
  3. Filtrate 100fold concentrated in tubules for favourable conc gradient for reabsorption by passive diffusion (LOH)
90
Q

Factors influencing renal excretion

A

Gender (f 80% RF)
Age (decreases 50% 25-75_
Pregnancy (increases 50%)
Disease (renal disease,heart failure)

91
Q

Alteration of renal excretion of drugs

A
  1. Comp inhibition of tubular secretion (RC of penicillin decreased 90% by probenecid to just filtration percent)
  2. Influence of pH (Sodium bicarbonate for increasing ionisation of weak acids and decreasing reabsorption (salicylate, methotrexate). Ammonium chloride used to acidify urine to enhance excretion of basic drugs (amphetamines)
  3. Influence of urinary flow rate (increase decreases conc gradient for passive reabsorption - flush drug out. Dehydration has opposite effect)
92
Q

Amphetamine overdose

A

Treat with Ammonium chloride to make urine acidic and increase excretion of amphetamine in overdose

93
Q

Prolong amphetamine effects

A

Take baking soda to increase pH of urine and decrease the excretion of amphetamine, prolonging the effect

94
Q

PD2’

A

Competitve irreversible antagonism

Medsci 204 (4 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions